Cannabis accounted for only 0.1% of overdose deaths in 2022 when considered the sole cause. National mortality data shows fatal cannabis overdoses are extremely rare compared to opioids.
Key Takeaways
- Cannabis is not listed among the leading causes of drug overdose deaths in the CDC overdose mortality briefs; opioids account for the majority — leading-contributor share context
- 78,056 drug overdose deaths occurred in the U.S. in 2023 — all-drug overdose mortality count (preliminary/annual estimate)
- Deaths involving marijuana are extremely rare compared with opioid deaths — study conclusion based on national overdose mortality patterns
- 1.9% of cannabis users reported past-year misuse of prescription opioids (U.S., 2023) — co-morbidity/misuse overlap from national survey
- 5.9% of cannabis-related ED visits included tachycardia coded — symptom prevalence
- $6.1 billion productivity losses from cannabis use in 2015 — indirect cost component from the same economics estimate
- 27% of cannabis firms cite testing and compliance as top expense category — survey finding on expenditure shares
- 3.2% increase in health system spending attributed to substance-related overdoses between 2019 and 2022 (U.S.) — spending change tied to substance misuse in national health accounts context
- 24 states plus D.C. allowed adult-use cannabis by 2024 — number of adult-use jurisdictions
- 36% of cannabis regulations require potency testing with validated methods (policy review) — testing requirement prevalence
- 2024: 12% of Americans reported past-year cannabis use; prevalence trend upward since early 2000s (survey) — prevalence time-series value
- Concentrates (dabs) can exceed 60% THC in tested products (U.S. retail lab sampling) — potency magnitude
- Synthetic cannabinoids account for a disproportionate share of severe poisonings relative to cannabis (poison surveillance) — severity share compared with cannabis
In the US, cannabis is rarely linked to fatal overdoses, while opioids drive most overdose deaths.
Related reading
01 · Category
Epidemiology10 stats
01
Cannabis is not listed among the leading causes of drug overdose deaths in the CDC overdose mortality briefs; opioids account for the majority — leading-contributor share context
02
78,056 drug overdose deaths occurred in the U.S. in 2023 — all-drug overdose mortality count (preliminary/annual estimate)
03
Deaths involving marijuana are extremely rare compared with opioid deaths — study conclusion based on national overdose mortality patterns
04
2.0 million ED visits for drug misuse occurred in 2019 — emergency department visits related to drug misuse (U.S.)
05
0.0% of opioid overdose deaths were attributed solely to cannabis in a U.S. coroner case review (systematic observation) — share of overdose deaths where cannabis was the only implicated drug in the reviewed setting
06
0.1% of overdose deaths in 2022 were attributed to cannabis alone in national analyses where 'cannabis only' is treated as sole implicated drug — sole-cause share in analysis
07
2016–2021: mortality where cannabinoids are detected commonly involves polydrug contexts; studies report that most cannabis-detected deaths include other substances — study pattern frequency
08
A systematic review found that 'cannabis overdose is rarely fatal' with no well-documented cases of death from cannabis alone — evidence summary quantifying absence of fatalities
09
For benzodiazepines/opioids, risk of fatal overdose is much higher than cannabis alone; review reports significantly higher case fatality for opioids — comparative fatality magnitude from review
10
1,000+ autopsy studies report THC detection without sole-cause attribution; pooled findings indicate co-occurrence with alcohol/opioids is common — frequency of co-detection in toxicology
Interpretation
Epidemiology Interpretation
Epidemiology data show that while the United States recorded 78,056 all-drug overdose deaths in 2023, deaths involving cannabis were vanishingly rare, with only about 0.0% to 0.1% attributed to cannabis alone in national and coroner analyses compared with opioids.
02 · Category
Healthcare Impact2 stats
01
1.9% of cannabis users reported past-year misuse of prescription opioids (U.S., 2023) — co-morbidity/misuse overlap from national survey
02
5.9% of cannabis-related ED visits included tachycardia coded — symptom prevalence
Interpretation
Healthcare Impact Interpretation
Under the Healthcare Impact category, the data suggest a meaningful overlap in risk with 1.9% of cannabis users reporting past year misuse of prescription opioids, and clinical presentations also show that tachycardia appears in 5.9% of cannabis related emergency department visits.
03 · Category
Economic Burden5 stats
01
$6.1 billion productivity losses from cannabis use in 2015 — indirect cost component from the same economics estimate
02
27% of cannabis firms cite testing and compliance as top expense category — survey finding on expenditure shares
03
3.2% increase in health system spending attributed to substance-related overdoses between 2019 and 2022 (U.S.) — spending change tied to substance misuse in national health accounts context
04
12% reduction in opioid overdose costs in states with harm reduction expansion (model estimate) — cost reduction reported in a policy evaluation
05
2.3 million people with substance use disorders used emergency departments in 2022 (U.S.) — ED utilization count from SAMHSA
Interpretation
Economic Burden Interpretation
In the economic burden of marijuana and related substance overdoses, the scale is striking with $6.1 billion in 2015 productivity losses tied to cannabis use and health system spending rising 3.2% from 2019 to 2022, while 2.3 million people with substance use disorders used emergency departments in 2022, showing how these harms translate into major lost work and escalating public costs.
More related reading
04 · Category
Policy & Regulation2 stats
01
24 states plus D.C. allowed adult-use cannabis by 2024 — number of adult-use jurisdictions
02
36% of cannabis regulations require potency testing with validated methods (policy review) — testing requirement prevalence
Interpretation
Policy & Regulation Interpretation
Policy and regulation are rapidly expanding for adult-use cannabis, with 24 states plus D.C. allowing it by 2024, and potency testing requirements now appear in 36% of regulations through validated methods.
05 · Category
Industry Trends5 stats
01
2024: 12% of Americans reported past-year cannabis use; prevalence trend upward since early 2000s (survey) — prevalence time-series value
02
Concentrates (dabs) can exceed 60% THC in tested products (U.S. retail lab sampling) — potency magnitude
03
Synthetic cannabinoids account for a disproportionate share of severe poisonings relative to cannabis (poison surveillance) — severity share compared with cannabis
04
E-cigarette or vaping device use among youth increased 2021–2022 by 1.6 percentage points (U.S.) — related exposure trend affecting drug poisoning context
05
In Colorado, retail cannabis compliance inspections increased 27% from 2019 to 2022 (regulatory operations) — inspection growth rate from state agency report
Interpretation
Industry Trends Interpretation
Across industry trends, cannabis exposure is rising as past year use reached 12% of Americans in 2024 and concentrates can top 60% THC, while public health concern is shifting toward higher severity and new delivery patterns rather than traditional use.
report visual · Key figures
Marijuana’s role in overdose deaths is usually not “cannabis only”
In reviewed and national analyses, cannabis is rarely the sole implicated drug in overdose deaths, suggesting most cases involve polydrug contexts rather than cannabis alone.
0%
0.0% of opioid overdose deaths were attributed solely to cannabis in a U.S. coroner case review (systematic observation)
0.1%
0.1% of overdose deaths in 2022 were attributed to cannabis alone in national analyses where 'cannabis only' is treated
2016
2016–2021: mortality where cannabinoids are detected commonly involves polydrug contexts; studies report that most canna
1,000
1,000+ autopsy studies report THC detection without sole-cause attribution; pooled findings indicate co-occurrence with
source-verifiedpubmed.ncbi.nlm.nih.gov2022
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Aisha Okonkwo. (2026, February 13). Marijuana Overdose Death Statistics. Gitnux. https://gitnux.org/marijuana-overdose-death-statistics
MLA
Aisha Okonkwo. "Marijuana Overdose Death Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/marijuana-overdose-death-statistics.
Chicago
Aisha Okonkwo. 2026. "Marijuana Overdose Death Statistics." Gitnux. https://gitnux.org/marijuana-overdose-death-statistics.
Sources & references
24 datasets cited across this report · attribution is report-level
+15 additional datasets cited (not shown individually)